The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
DHA supplementation and pregnancy outcomes
Open accessAbstract
Background Observational studies associate higher intakes of n-3 (omega-3) long-chain polyunsaturated fatty acids (LCPUFAs) during pregnancy with higher gestation duration and birth size. The results of randomized supplementation trials using various n-3 LCPUFA sources and amounts are mixed.Objective We tested the hypothesis that 600 mg/d of the n-3 LCPUFA docosahexaenoic acid (DHA) can increase maternal and newborn DHA status, gestation duration, birth weight, and length. Safety was assessed.Design This phase III, double-blind, randomized controlled trial was conducted between January 2006 and October 2011. Women (n = 350) consumed capsules (placebo, DHA) from <20 wk of gestation to birth. Blood (enrollment, birth, and cord) was analyzed for red blood cell (RBC) phospholipid DHA. The statistical analysis was intent-to-treat.Results Most of the capsules were consumed (76% placebo; 78% DHA); the mean DHA intake for the treated group was 469 mg/d. In comparison with placebo, DHA supplementation resulted in higher maternal and cord RBC-phospholipid-DHA (2.6%; P < 0.001), longer gestation duration (2.9 d; P = 0.041), and greater birth weight (172 g; P = 0.004), length (0.7 cm; P = 0.022), and head circumference (0.5 cm; P = 0.012). In addition, the DHA group had fewer infants born at <34 wk of gestation (P = 0.025) and shorter hospital stays for infants born preterm (40.8 compared with 8.9 d; P = 0.026) than did the placebo group. No safety concerns were identified.Conclusions A supplement of 600 mg DHA/d in the last half of gestation resulted in overall greater gestation duration and infant size. A reduction in early preterm and very-low birth weight could be important clinical and public health outcomes of DHA supplementation. This trial was registered at clinicaltrials.gov as NCT00266825.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DHA supplementation also resulted in longer gestation duration (2.9 day; P = 0.041), greater birth weight (172 g; P = 0.004), birth length (0.7 cm; P = 0.022), and head circumference (0.5 cm; P = 0.012).”
From Role of n-3 long-chain polyunsaturated fatty acids in human nutrition and health: Review of recent studies and recommendations (2021) · cites this paper as [131]
In the citing paper
“Preterm infants born in the DHA-supplemented group had a shorter hospital stay than that in the placebo group (8.9 vs. 40.8 days; P = 0.026).”
From Role of n-3 long-chain polyunsaturated fatty acids in human nutrition and health: Review of recent studies and recommendations (2021) · cites this paper as [131]
In the citing paper
“Data from another recent double-blind, randomized, and controlled intervention trial involving 530 women who, from 20 weeks of gestation till birth, received either a DHA-rich algal oil capsule (providing 600 mg/day of DHA) or a matched vegetable oil capsules without DHA also demonstrated reduced incidence of premature birth in the DHA group [131].”
From Role of n-3 long-chain polyunsaturated fatty acids in human nutrition and health: Review of recent studies and recommendations (2021) · cites this paper as [131]
In the citing paper
“In addition, the data demonstrated fewer infants born at < 34 weeks of gestation in the DHA-supplemented group compared to that in the placebo group (P = 0.025).”
From Role of n-3 long-chain polyunsaturated fatty acids in human nutrition and health: Review of recent studies and recommendations (2021) · cites this paper as [131]
In the citing paper
“The mean DHA intake for the DHA-supplemented group was 469 mg/day, resulting in higher maternal and cord RBC-phospholipid-DHA levels (2.6%; P < 0.001) than those in the placebo group.”
From Role of n-3 long-chain polyunsaturated fatty acids in human nutrition and health: Review of recent studies and recommendations (2021) · cites this paper as [131]
In the citing paper
“There were no reported adverse effects and no safety concerns were identified in the DHA group.”
From Role of n-3 long-chain polyunsaturated fatty acids in human nutrition and health: Review of recent studies and recommendations (2021) · cites this paper as [131]
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride–methanol
Morrison, W. R., & Smith, L. M. (1964) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40190-7 · Cited by 6,005
Martin, J. A., Hamilton, B. E., Ventura, S. J., Osterman, M. J. K., Kirmeyer, S., Mathews, T. J., & Wilson, E. C. (2011) · PubMed · Cited by 700
Makrides, M., Gibson, R. A., McPhee, A. J., Yelland, L., Quinlivan, J., Ryan, P., & DOMInO Investigative Team, A. T. (2010) · JAMA · doi:10.1001/jama.2010.1507 · Cited by 559
Randomised clinical trials of fish oil supplementation in high risk pregnancies
Olsen, S. F., Secher, N. J., Tabor, A., Weber, T., Walker, J. J., & Gluud, C. N. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb13235.x · Cited by 360
Helland, I. B., Saugstad, O. D., Smith, L., Saarem, K., Solvoll, K., Ganes, T., & Drevon, C. A. (2001) · PEDIATRICS · doi:10.1542/peds.108.5.e82 · Cited by 347
Makrides, M., Duley, L., & Olsen, S. F. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003402.pub2 · Cited by 293
Omega 3 fatty acids on child growth, visual acuity and neurodevelopment
Campoy, C., Escolano-Margarit, M. V., Anjos, T. G., Szajewska, H., & Uauy, R. D. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512001493 · Cited by 263
Recommendations for Weight Gain During Pregnancy in the Context of the Obesity Epidemic
Rasmussen, K. M., Abrams, B. F., Bodnar, L. M., Butte, N. F., Catalano, P. M., & Siega‐Riz, A. M. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181f60da7 · Cited by 246
A Randomized Trial of Docosahexaenoic Acid Supplementation During the Third Trimester of Pregnancy
Smuts, C. M., Huang, M., Mundy, D., Plasse, T., Major, S., & Carlson, S. E. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02585-1 · Cited by 243
Flagged first, then by citations
Research works printed but not linked: 1
- 2008, QuickStats: mean gestational age, by plurality—United States, 2005, MMWR Morb Mortal Wkly Rep, 57, 225
Cited by
Sorted by citations
Items 101–200 of 328
Olsen, S. F., Halldorsson, T. I., Li, M., Strøm, M., Mao, Y., Che, Y., Wang, Y., Duan, F., Olsen, J., & Zhou, W. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz153 · Cited by 26
Khandelwal, S., Kondal, D., Chaudhry, M., Patil, K., Swamy, M. K., Metgud, D., Jogalekar, S., Kamate, M., Divan, G., Gupta, R., et al. (2020) · Nutrients · doi:10.3390/nu12103041 · Cited by 29
The role of specialized pro-resolving mediators in maternal-fetal health
Elliott, E., Hanson, C., Anderson‐Berry, A., & Nordgren, T. M. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.09.017 · Cited by 26
Gupta, M., Solanki, M. H., Chatterjee, P. K., Xue, X., Roman, A., Desai, N., Rochelson, B. L., & Metz, C. N. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00137 · Cited by 25
Hidaka, B. H., Thodosoff, J. M., Kerling, E. H., Hull, H. R., Colombo, J. A., & Carlson, S. E. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqx007 · Cited by 25
“Currently most women in the United States enter pregnancy either overweight or obese, and many of those gain excessively as was true of women in this cohort (13).”
BackgroundMethodInfluentialSelf-citationWilson, N. A., Mantzioris, E., Middleton, P., & Mühlhäusler, B. S. (2019) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2019.102037 · Cited by 26
Fatty acids in normal and pathological pregnancies
Mauro, A. K., Rengarajan, A., Albright, C., & Boeldt, D. S. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111466 · Cited by 25
Heterogeneity in cord blood DHA concentration: Towards an explanation
Mühlhäusler, B. S., Gibson, R. A., Yelland, L., & Makrides, M. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.07.013 · Cited by 25
Wadhwani, N. S., Narang, A. S., Mehendale, S. S., Wagh, G. N., Gupte, S., & Joshi, S. (2015) · Lipids · doi:10.1007/s11745-015-4098-5 · Cited by 25
“Studies have reported that higher intake of 22:6n-3 reduces the risk of preterm birth and increases the length of gestation and birth weight of the newborn [11, 12].”
BackgroundLee, E.-J., Kim, H., Kim, H.-J., Ha, E., & Chang, N. (2018) · Nutrition Journal · doi:10.1186/s12937-018-0353-y · Cited by 30
A Prenatal DHA Test to Help Identify Women at Increased Risk for Early Preterm Birth: A Proposal
Jackson, K. H., & Harris, W. S. (2018) · Nutrients · doi:10.3390/nu10121933 · Cited by 24
“For example, DHA or fish oil supplementation has had beneficial effects in the following areas: in term and PT infants—visual and neurodevelopment [17,30,31], sleep quality [32], autonomic function [33]; and in toddlers and children—cognitive function [34–36], ability to focus [37], risk of asthma and wheezing [38], a…”
BackgroundInfluentialIrwinda, R., Hiksas, R., Siregar, A. A., Saroyo, Y. B., & Wibowo, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-93846-w · Cited by 25
Long-chain polyunsaturated fatty acids supplementation in preterm infants
Uauy, R. D., & Mena, P. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000203 · Cited by 24
Marano, D., da Silva, L. M. L., Guimarães, A. C. L. D., Moreira, M. E. L., & do Amaral, Y. N. D. V. (2017) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0037-1599094 · Cited by 25
Addo, E. K., Gorusupudi, A., Allman, S. J., & Bernstein, P. S. (2021) · Trials · doi:10.1186/s13063-021-05244-2 · Cited by 23
REMOVED: Position of the Academy of Nutrition and Dietetics: Vegetarian Diets
Cullum‐Dugan, D., & Pawlak, R. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2015.02.033 · Cited by 24
RetractedKeenan, K. E., Hipwell, A. E., McAloon, R. L., Hoffmann, A. M., Mohanty, A., & Magee, K. E. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.05.023 · Cited by 23
Ren, X., Vilhjálmsdóttir, B. L., Rohde, J. F., Walker, K. C., Runstedt, S. E., Lauritzen, L., Heitmann, B. L., & Specht, I. O. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.625596 · Cited by 23
“Some of the studies limited inclusion by maternal prepregnancy weight in the range of 50–92 kg (53, 54) or prepregnancy BMI <30 kg/m2 (65), between 18 and 30 kg/m2 (55, 56, 66), or <40 kg/m2 (46, 47, 64).”
BackgroundInfluentialValentine, C. J., Khan, A. Q., Brown, A. R., Sands, S. A., DeFranco, E., Gajewski, B. J., Carlson, S. E., Reber, K. M., & Rogers, L. K. (2021) · Nutrients · doi:10.3390/nu13124248 · Cited by 22
Self-citationChen, B., Ji, X., Zhang, L., Hou, Z., Li, C.-D., & Tong, Y. (2015) · Medical Science Monitor · doi:10.12659/msm.894033 · Cited by 23
“However, further randomized controlled trials (RCTs) did not support that gestational supplementation with fish oil can reduce the risks for GDM, PIH, or PE.”
ResultInfluentialCarlson, S. E., Gajewski, B. J., Hayek, S. A., Colombo, J. A., Kerling, E. H., & Gustafson, K. M. (2018) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.09.002 · Cited by 22
Self-citationWu, Y., 烟王, Y. W., Tian敏田慧, H., Lu逯通, T., Yu苗于, M., Xu慧徐文, W., Liu良刘国, G., & Xie林谢, L. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m090951 · Cited by 22
Exposure to arsenolipids and inorganic arsenic from marine-sourced dietary supplements
Taylor, V. F., & Karagas, M. R. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.133930 · Cited by 23
Zhou, S. J., Best, K. P., Gibson, R. A., McPhee, A. J., Yelland, L. N., Quinlivan, J. A., & Makrides, M. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018360 · Cited by 21
Vanheule, G., Ceulemans, D., Vynckier, A.-K., Mulder, P. D., Driessche, M. V. D., & Devlieger, R. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05546-z · Cited by 21
Meeting the fetal requirement for polyunsaturated fatty acids in pregnancy
Haggarty, P. (2014) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000036 · Cited by 20
Amorim, T. L., de la Fuente, M. Á., de Oliveira, M. A. L., & Gómez‐Cortés, P. (2021) · ACS Food Science & Technology · doi:10.1021/acsfoodscitech.0c00122 · Cited by 20
Li, Y., Li, H., Trasande, L., Ge, H., Yu, L., Xu, G., Bai, M.-X., & Liu, J. (2015) · Nutrients · doi:10.3390/nu7105428 · Cited by 19
“Increased intake of DHA during pregnancy and lactation has been documented to benefit fetal and infant development [4–7].”
BackgroundMoltó-Puigmartí, C., DONGEN, M. C. J. M. V., Dagnelie, P. C., Plat, J., Mensink, R. P., Tan, F. E. S., Heinrich, J., & Thijs, C. T. (2014) · Journal of Nutrition · doi:10.3945/jn.114.194035 · Cited by 19
“(17) found that the effect of DHA supplementation on BW was greater than would be expected from the effect on pregnancy duration.”
BackgroundJudge, M. P., Casavant, S. G., Dias, J. A. M., & McGrath, J. M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw006 · Cited by 19
“Carlson et al.(59) conducted a phase III, double-blind, randomized control trial and found that the DHA supplementation group (600 mg/d) had a longer gestation (2.”
BackgroundInfluentialChristian, L. M., Young, A. S., Mitchell, A. M., Belury, M. A., Gracious, B., Arnold, L. E., & Fristad, M. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173087 · Cited by 19
Effect of Docosahexaenoic Acid on Apoptosis and Proliferation in the Placenta: Preliminary Report
Wietrak, E., Kamiński, K., Leszczyńska‐Gorzelak, B., & Oleszczuk, J. (2015) · BioMed Research International · doi:10.1155/2015/482875 · Cited by 19
Electroencephalographic study of microalgae DHA omega-3 egg consumption on cognitive function
Kaewsutas, M., Sarikaphuti, A., Nararatwanchai, T., Sittiprapaporn, P., & Patchanee, P. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.12.004 · Cited by 18
Smith, M. E., Cisbani, G., Lacombe, R. J. S., & Bazinet, R. P. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab246 · Cited by 18
Both maternal and offspring Elovl2 genotypes determine systemic DHA levels in perinatal mice
Pauter, A. M., Trattner, S., González-Bengtsson, A., Talamonti, E., Asadi, A., Dethlefsen, O., & Jacobsson, A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m070862 · Cited by 18
Gawlik, N. R., Anderson, A. J., Makrides, M., Kettler, L. J., & Gould, J. F. (2020) · Nutrients · doi:10.3390/nu12103106 · Cited by 17
“Mothers took capsules with DHA doses of 120 [26], 300 [83], 400 [27,28,51,52], 450 [81,82], 600 [79,80], 800 [25,77,78], 1020 [58], 1100 [55], and 2200 [75,76] mg per day.”
Carlson, S. E., Gajewski, B. J., Valentine, C. J., Sands, S. A., Brown, A. R., Kerling, E. H., Crawford, S., Buhimschi, C. S., Weiner, C. P., Cackovic, M., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.01.009 · Cited by 17
Self-citationSaros, L., Vahlberg, T. J., Koivuniemi, E., Houttu, N., Niinikoski, H., Tertti, K., & Laitinen, K. (2022) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003659 · Cited by 17
Khaire, A. A., Rathod, R. S., Kemse, N. G., Kale, A. A., & Joshi, S. (2013) · Reproduction Fertility and Development · doi:10.1071/rd13306 · Cited by 17
“Recent reports indicate that DHA supplementation has beneficial effects in improving pregnancy outcome and infant size (Greenberg et al. 2008; reviewed by Coletta et al. 2010; Carlson et al. 2013).”
BackgroundOstadrahimi, A., Mohammad‐Alizadeh‐Charandabi, S., Mirghafourvand, M., Farshbaf-Khalili, S., Jafarilar, N., & Farshbaf‐Khalili, A. (2017) · Journal of Perinatal Medicine · doi:10.1515/jpm-2016-0037 · Cited by 17
“The number of infants born before 34 weeks was also significantly less in the intervention group [21].”
BackgroundKhandelwal, S., Kondal, D., Chaudhry, M., Patil, K., Swamy, M. K., Pujeri, G., Mane, S. B., Kudachi, Y., Gupta, R., Ramakrishnan, U., et al. (2021) · Nutrients · doi:10.3390/nu13030730 · Cited by 17
“In the United States of America, DHA supplementation resulted in longer gestation duration (2.9 d; p = 0.041) and greater birth weight (172 g; p = 0.004), length (0.7 cm; p = 0.022), and head circumference (HC) (0.5 cm; p = 0.012) [20].”
BackgroundInfluentialSun, L., Li, Y., Xie, W., & Xue, X. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1785423 · Cited by 16
Amorim, T. L., Duarte, L. M., de la Fuente, M. Á., de Oliveira, M. A. L., & Gómez‐Cortés, P. (2019) · Journal of Chromatography A · doi:10.1016/j.chroma.2019.460641 · Cited by 16
Feltham, B. A., Louis, X. L., Eskin, M., & Suh, M. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz135 · Cited by 20
“A recently published article that re-analyzed 2 clinical trials [Donor Milk for Improved Neurodevelopmental Outcomes (DOMInO) (117) and Kansas University DHA Outcome Study (KUDOS) (118)] showed a significant reduction in the incidence of preterm birth with 800 mg (DOMInO) and 600 mg (KUDOS)/d of DHA supplementation in…”
BackgroundZhao, R., Gao, Q. F., Wang, S., Yang, X., & Hao, L. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1802573 · Cited by 16
“…protein, vitamins and other essential nutrients, including long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA), which have been suggested providing beneficial effects on pregnancy outcomes (Carlson et al. 2013; De Giuseppe, Roggi, and Cena 2014; Szajewska, Horvath, and Koletzko 2006).”
BackgroundInfluentialZhou, Y.-B., Li, H., Trasande, L., Wang, L., Zhang, Y., Si, K., Bai, M.-X., & Liu, J. (2017) · Nutrients · doi:10.3390/nu9111256 · Cited by 16
“9 days and increasing birth weight of the newborn by up to 172 g [4].”
BackgroundDocosahexaenoic acid supplementation (DHA) and the return on investment for pregnancy outcomes
Shireman, T. I., Kerling, E. H., Gajewski, B. J., Colombo, J., & Carlson, S. E. (2016) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.05.008 · Cited by 15
“Participants for whom delivery data were available self-identified as Black (42”
BackgroundResultInfluentialSelf-citationChowdhury, M. H., Ghosh, S., Kabir, M. R., Mamun, M. A. A., & Islam, M. S. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1786522 · Cited by 17
“Author (Year) Items Randomization Double blinding Withdrawals & dropouts Total Ali et al. 2017 2 0 1 3 Bulstra-Ramakers et al. 1995 2 2 1 5 Carlson et al. 2013 2 2 1 5 De Groot et al. 2004 2 2 1 5 Freeman et al. 2008 2 2 1 5 Giorlandino et al. 2013 2 2 1 5 Gustafson et al. 2013 2 2 1 5 Haghiac et…”
BackgroundZhang, C., Garrard, L., Keighley, J. D., Carlson, S., & Gajewski, B. J. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-1189-0 · Cited by 15
Self-citationFonseca, P. A. D. S., Suárez‐Vega, A., & Cánovas, Á. (2022) · Functional & Integrative Genomics · doi:10.1007/s10142-022-00893-1 · Cited by 15
Preterm labour: association between labour physiology, tocolysis and prevention
Illanes, S. E., Pérez‐Sepúlveda, A., Rice, G. E., & Mitchell, M. D. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.905541 · Cited by 15
“All these findings allow us to infer that DHA supplementation in the last half of gestation reduces the risk of PTB and improves foetal outcome [83,84].”
BackgroundFish oil supplemental dose needed to reach 1 g% DHA+EPA in mature milk
Stoutjesdijk, E., Schaafsma, A., Dijck-Brouwer, J., & Muskiet, F. A. J. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.11.003 · Cited by 16
“It was previously shown that RBC DHA contents of 7.3 [37] and 7.2 g% [38] at the pregnancy end were reached by supplementing 600 mg DHA for 25 weeks and 1200 mg for 17 weeks, respectively.”
MethodInfluentialMaternal Vitamin D Status and Infant Infection
Moukarzel, S., Ozias, M. K., Kerling, E. H., Christifano, D. N., Wick, J., Colombo, J. A., & Carlson, S. E. (2018) · Nutrients · doi:10.3390/nu10020111 · Cited by 15
“This study involved 220 mother–infant dyads who participated in the Kansas University DHA Outcomes Study (KUDOS)—a randomized, double-blind, placebo-controlled clinical trial for which the primary goal was to determine whether prenatal docosahexaenoic acid (DHA) supplementation could improve pregnancy outcomes and inf…”
MethodSelf-citationCrawford, S., Christifano, D. N., Kerling, E. H., Gajewski, B. J., Valentine, C., Gustafson, K., Mathis, N., Camargo, J. T., Gibbs, H. A., Sullivan, D. K., et al. (2022) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102398 · Cited by 16
Self-citationThompson, M. K., Ulu, A., Yuil-Valdes, A. G., Mukherjee, M. S., Thoene, M. K., Ormer, M. V., Slotkowski, R., Lyden, E. R., Anderson‐Berry, A., Hanson, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020708 · Cited by 15
“A phase III randomized controlled trial in which a cohort of women received supplemental n-3 FAs during pregnancy revealed that this intervention increased infant birth weight, length, and head circumference [15].”
BackgroundCarlson, S. E., & Colombo, J. A. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab299 · Cited by 15
Self-citationBilgundi, K., Viswanatha, G. L., Purushottam, K. M., John, J., Kamath, A. P., Kishore, A., Nayak, P. G., & Nandakumar, K. (2024) · Nutrition Research · doi:10.1016/j.nutres.2024.06.008 · Cited by 14
Science-based policy: targeted nutrition for all ages and the role of bioactives
Kalache, A., Bazinet, R. P., Carlson, S. E., Evans, W. J., Kim, C. H., Lanham-New, S. A., Visioli, F., & Griffiths, J. C. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02662-5 · Cited by 14
“1 3 In addition to cognitive benefits of prenatal supplementation and evidence of differences in brain function in both prenatally and postnatally DHA exposure children, other benefits related to prenatal supplementation (despite what might be considered good postnatal supplementation) became apparent, including a red…”
BackgroundSelf-citationAhmed, S., Makrides, M., Sim, N., McPhee, A., Quinlivan, J. A., Gibson, R. A., & Umberger, W. J. (2015) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2015.08.002 · Cited by 13
Dioxin-like Activity in Pregnant Women and Indices of Fetal Growth: The ACCEPT Birth Cohort
Long, M., Wielsøe, M., & Bonefeld‐Jørgensen, E. C. (2022) · Toxics · doi:10.3390/toxics10010026 · Cited by 13
Hidaka, B. H., Kerling, E. H., Thodosoff, J. M., Sullivan, D. K., Colombo, J. A., & Carlson, S. E. (2016) · BMC Pediatrics · doi:10.1186/s12887-016-0729-0 · Cited by 13
“We are extensively phenotyping a cohort of children from a randomized controlled trial of high dose prenatal docosahexaenoic acid (DHA) supplementation [17].”
BackgroundSelf-citationGustafson, K. M., Liao, K., Mathis, N. B., Shaddy, D. J., Kerling, E. H., Christifano, D. N., Colombo, J., & Carlson, S. E. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1712535 · Cited by 13
“women with 600 mg/day DHA during the last two trimesters of pregnancy reduced early preterm birth [10], improved standardized measures of fetal heart rate variability and resulted in higher autonomic and motor scores”
BackgroundInfluentialSelf-citationHao, Y., Sun, X., Wen, N., Song, D., & Li, H. (2021) · Archives of Medical Science · doi:10.5114/aoms/141577 · Cited by 13
“The studies were excluded for the following reasons: no qualified studies (21), lack of clinical outcomes (27), review or theory research (8), and non-RCT studies (18).”
BackgroundWahab, R. J., Jaddoe, V. W. V., Mezzoiuso, A. G., & Gaillard, R. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.02.012 · Cited by 13
Presentation and management of acute hypertriglyceridemic pancreatitis in pregnancy: A case report
Lim, R., Rodger, S. J., & Hawkins, T. L. (2015) · Obstetric Medicine · doi:10.1177/1753495x15605697 · Cited by 13
Hidaka, B. H., Kimler, B. F., Fabian, C. J., & Carlson, S. E. (2016) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2016.10.008 · Cited by 13
Self-citationMaternal high-fat diet influences outcomes after neonatal hypoxic-ischemic brain injury in rodents
Barks, J., Liu, Y., Shangguan, Y., Djurić, Z., Ren, J., & Silverstein, F. S. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15624934 · Cited by 13
“In randomized trials done at our institution and others, n-3 fatty acid supplementation resulted in slightly longer gestation and increased birth weight of infants.(42,43) There has been substantial enthusiasm for DHA supplementation to pregnant women and their infants; however, inconsistent clinical benefits have bee…”
ResultStrom, C. J., McDonald, S. M., Remchak, M. E., Kew, K. A., Rushing, B. R., Houmard, J. A., Tulis, D. A., Pawlak, R., Kelley, G. A., Chasan‐Taber, L., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19148293 · Cited by 13
Mujica-Coopman, M. F., Franco‐Sena, A. B., Farias, D. R., Vaz, J. D. S., Alex Brito, O., Kac, G., & Lamers, Y. (2016) · Journal of Nutrition · doi:10.3945/jn.116.239483 · Cited by 12
Hoge, A., Donneau, A., Dardenne, N., Degée, S., Timmermans, M., Nisolle, M., Guillaume, M., & Castronovo, V. (2020) · Journal of Perinatology · doi:10.1038/s41372-019-0573-9 · Cited by 12
Farshbaf‐Khalili, A., Mohammad‐Alizadeh‐Charandabi, S., Darabi, M., Hemmatzadeh, S., Mehdizadeh, A., Shaaker, M., & Ostadrahimi, A. (2016) · Women & Health · doi:10.1080/03630242.2016.1159269 · Cited by 12
“It seems that the baseline serum levels of DHA and EPA may have a role on breaking of FAs from adipose tissue in pregnancy.”
BackgroundResultInfluentialNeuroinflammation in fetal alcohol spectrum disorders and related novel therapeutic approaches
Padilla-Valdez, M. M., Díaz-Iñiguez, M. I., Ortuño‐Sahagún, D., & Rojas-Mayorquín, A. E. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166854 · Cited by 10
Wei, T., He, Y., Tan, D., Zeng, X., Hou, Y., Wang, J., Jiang, H., Deng, Z., & Li, J. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.140955 · Cited by 12
Kerling, E. H., Hilton, J. M., Thodosoff, J. M., Wick, J., Colombo, J. A., & Carlson, S. E. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.0088 · Cited by 11
Self-citationCommensurate Priors on a Finite Mixture Model for Incorporating Repository Data in Clinical Trials
Gajewski, B. J., Reese, C. S., Colombo, J. A., & Carlson, S. E. (2016) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2015.1133453 · Cited by 11
“A recently completed Phase III trial (called Kansas University DHA Outcomes Study, KUDOS) (Carlson et al. 2013) revealed that higher average birth weight and gestational age were associated with DHA supplementation of 600 mg/day in the second and third trimesters (see also Helland et al. 2001; Smuts et al. 2003; Makri…”
BackgroundSelf-citationBaker, E. J., Calder, P. C., Kermack, A., Brown, J. E., Mustapha, M., Kitson-Reynolds, E., & Garvey, J. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1502866 · Cited by 10
Maternal Nutrition and Birth Outcomes
Ramakrishnan, U., Young, M., & Martorell, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-43739-2_22 · Cited by 256
Jugendheilkunde, E. D. Ö. G. F. K. U., & Plank, R. (2018) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-018-0554-7 · Cited by 10
Omega-3 Consumption During Pregnancy to Support Optimal Outcomes
Judge, M. P. (2017) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1016/j.jogn.2017.06.004 · Cited by 10
Maschio, M. C. E., Zarabla, A., Maialetti, A., Marchesi, F., Giannarelli, D., Gumenyuk, S., Pisani, F., Renzi, D., Galiè, E., & Mengarelli, A. (2019) · Integrative Cancer Therapies · doi:10.1177/1534735419888584 · Cited by 11
Christifano, D. N., Chollet-Hinton, L., Mathis, N. B., Gajewski, B. J., Carlson, S. E., Colombo, J., & Gustafson, K. M. (2022) · The Journal of Nutrition · doi:10.1093/jn/nxac178 · Cited by 10
Self-citationGe, H., Huang, D., Tan, L., Luo, D., Zhou, L., Liu, H., Zhang, Y., Liu, D., Wu, X., Wang, L., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf057 · Cited by 9
“This imbalance may impair the fetus ’ s acquisition of essential fatty acids, thereby affecting the brain (56, 57) and retinal development (58) and increasing the risk of premature labor or low birth weight (59).”
Robinson, D. T., Horn, L. V., Balmert, L. C., Silver, R. M., Parry, S. I., Haas, D. M., Wing, D. A., & Grobman, W. A. (2021) · Current Developments in Nutrition · doi:10.1093/cdn/nzab074 · Cited by 9
“There is interest in supplementation as it has reportedly been associated with reduced frequency of PTB in some, but not all, clinical trials (9, 11).”
BackgroundVafai, Y., Yeung, E. H., Roy, A., He, D., Li, M., Hinkle, S. N., Grobman, W. A., Newman, R., Gleason, J. L., Ayele, F. T., et al. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.08.007 · Cited by 11
Addo, E. K., Allman, S. J., Arunkumar, R., Gorka, J. E., Harrison, D. Y., Varner, M. W., & Bernstein, P. S. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.05.024 · Cited by 9
Keenan, K. E., & Hipwell, A. E. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu020 · Cited by 9
Ozias, M. K., Kerling, E. H., Christifano, D. N., Scholtz, S. A., Colombo, J. A., & Carlson, S. E. (2014) · Journal of the American College of Nutrition · doi:10.1080/07315724.2013.879843 · Cited by 11
“A primary aim of the parent study was to determine whether a daily supplement of 600 mg of DHA during pregnancy affected gestation duration and birth size; therefore, we included red blood cell phospholipid DHA as a percentage of total fatty acids as a covariate [9].”
BackgroundSelf-citationMaternal and fetal benefits of DHA supplementation during pregnancy
Hubinont, C., & Savoye, T. (2017) · Journal of Pregnancy and Reproduction · doi:10.15761/jpr.1000103 · Cited by 9
“In a double blind RCT including 350 women receiving either 600mg/d DHA or placebo, the authors found that supplementation during the last half of gestation resulted in overall greater gestation duration and infant size [8].”
BackgroundLima, H. K., Lin, X., Jacobi, S. K., Man, C., Sommer, J. R., Flowers, W. L., Blikslager, A. T., Gonzalez, L. M., & Odle, J. (2017) · Current Developments in Nutrition · doi:10.3945/cdn.117.001958 · Cited by 9
“Additionally, although the importance of omega 3’s in brain development is well established (29) and choline has been implicated in brain development (30), this may indicate a synergistic role for B-vitamins in supporting brain development in utero, as supplementation with a B-vitamin cocktail was able to normalize br…”
BackgroundJiang, Y., Zhou, X., He, Z., Wei, L., Zhu, S., Zhang, H., Zhang, J., Chen, Y., Du, Y., Ding, W., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116726 · Cited by 9
Sarsmaz, K., Göker, A., Mıçılı, S. Ç., Ergür, B. U., & Kuşçu, N. K. (2016) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2016.04.011 · Cited by 8
“High omega-3 diets appear to cause growth retardation [21] or to increase birth weight [22].”
BackgroundGould, J. F., Anderson, P. J., Yelland, L. N., Gibson, R. A., & Makrides, M. (2021) · Nutrients · doi:10.3390/nu13092996 · Cited by 10
Ghazal, R. M., & Naffaa, M. M. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2025.1004107 · Cited by 12
Harmonizing blood DHA levels in pregnancy studies: An interlaboratory investigation
Jackson, K. H., & Harris, W. S. (2022) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102417 · Cited by 7
Osuna, E., Symington, E. A., Malan, L., Ricci, C., Zandberg, L., Smuts, C. M., & Baumgartner, J. (2023) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102528 · Cited by 7
Khaire, A. A., Rathod, R. S., Kale, A. A., & Joshi, S. (2016) · Archives of Medical Research · doi:10.1016/j.arcmed.2016.10.006 · Cited by 7
Lei, Y., Carlson, S. E., Yelland, L. N., Makrides, M., Gibson, R. A., & Gajewski, B. J. (2016) · Journal of Applied Statistics · doi:10.1080/02664763.2016.1214244 · Cited by 7
“1%, difference = 3%) based on our previous clinical trial results [2].”
BackgroundMethodResultInfluentialSelf-citationMatsuda, S., Kuwabara, Y., Taketomi, Y., Nagasaki, Y., Sugita, Y., Suzuki, S., Manabe, I., Murakami, M., & Oishi, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1547949 · Cited by 7
Global Comparison of Erythrocyte EPA and DHA Concentrations in Pregnant Women
Deutsch, T., Harris, W. S., Jackson, K. H., Hahn, A., & Schuchardt, J. P. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.101299 · Cited by 6
DHA (Docosahexaenoic Acid): A Biomolecule with Diverse Roles and Health Benefits
Hei, A., & Sanahanbi, L. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109677 · Cited by 7
Metadata
- Authors
- Carlson, S. E., Colombo, J., Gajewski, B. J., Gustafson, K. M., Mundy, D., Yeast, J., Georgieff, M. K., Markley, L. A., Kerling, E. H., & Shaddy, D. J.
- Affiliations
- University of Kansas Medical Center (US)
- University of Kansas (US)
- University of Missouri–Kansas City (US)
- ORCID
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 97
- Issue
- 4
- Pages
- 808-815
- ISSN
- 0002-9165 (ISSN-L)
- PMC
- PMC3607655
- OpenAlex
- W2136748312
- Cited by
- 329
- References
- 21
- Citations by year
- 2026: 15 · 2025: 18 · 2024: 20 · 2023: 17 · 2022: 36 · 2021: 31 · 2020: 24 · 2019: 22 · 2018: 21 · 2017: 24 · 2016: 35 · 2015: 34 · 2014: 25 · 2013: 6
- FWCI
- 30.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Deafness and Other Communication Disorders (P30DC005803)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD02528, R01HD047315, P30HD002528)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- docosahexaenoic acid, DHA supplementation, pregnancy, omega-3 fatty acids, gestation length, birth weight, birth length, preterm birth, very low birth weight, red blood cell phospholipids, supplement safety
- MeSH terms
- Adult, Birth Weight, Body Height, Dietary Fats, Docosahexaenoic Acids, Double-Blind Method, Erythrocytes, Female, Gestational Age, Head, Humans, Infant, Newborn, Infant, Premature, Length of Stay, Phospholipids, Pregnancy, Pregnancy Outcome, Umbilical Cord, Dietary Supplements, Fetal Development, Premature Birth, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review